TY - JOUR
T1 - Fourth consensus of the International Society for Premenstrual Disorders (ISPMD)
T2 - auditable standards for diagnosis and management of premenstrual disorder
AU - Ismaili, Elgerta
AU - Walsh, Sally
AU - O’Brien, Patrick Michael Shaughn
AU - Bäckström, Torbjorn
AU - Brown, Candace
AU - Dennerstein, Lorraine
AU - Eriksson, Elias
AU - Freeman, Ellen W.
AU - Ismail, Khaled M.K.
AU - Panay, Nicholas
AU - Pearlstein, Teri
AU - Rapkin, Andrea
AU - Steiner, Meir
AU - Studd, John
AU - Sundström-Paromma, Inger
AU - Endicott, Jean
AU - Epperson, C. Neill
AU - Halbreich, Uriel
AU - Reid, Robert
AU - Rubinow, David
AU - Schmidt, Peter
AU - Yonkers, Kimberley
AU - Consensus Group of the International Society for Premenstrual Disorders, Group of the International Society for Premenstrual Disorders
N1 - Publisher Copyright:
© 2016, Springer-Verlag Wien.
PY - 2016/12/1
Y1 - 2016/12/1
N2 - Whilst professional bodies such as the Royal College and the American College of Obstetricians and Gynecologists have well-established standards for audit of management for most gynaecology disorders, such standards for premenstrual disorders (PMDs) have yet to be developed. The International Society of Premenstrual Disorders (ISPMD) has already published three consensus papers on PMDs covering areas that include definition, classification/quantification, clinical trial design and management (American College Obstetricians and Gynecologists 2011; Brown et al. in Cochrane Database Syst Rev 2:CD001396, 2009; Dickerson et al. in Am Fam Physician 67(8):1743–1752, 2003). In this fourth consensus of ISPMD, we aim to create a set of auditable standards for the clinical management of PMDs. All members of the original ISPMD consensus group were invited to submit one or more auditable standards to be eligible in the inclusion of the consensus. Ninety-five percent of members (18/19) responded with at least one auditable standard. A total of 66 auditable standards were received, which were returned to all group members who then ranked the standards in order of priority, before the results were collated. Proposed standards related to the diagnosis of PMDs identified the importance of obtaining an accurate history, that a symptom diary should be kept for 2 months prior to diagnosis and that symptom reporting demonstrates symptoms in the premenstrual phase of the menstrual cycle and relieved by menstruation. Regarding treatment, the most important standards were the use of selective serotonin reuptake inhibitors (SSRIs) as a first line treatment, an evidence-based approach to treatment and that SSRI side effects are properly explained to patients. A set of comprehensive standards to be used in the diagnosis and treatment of PMD has been established, for which PMD management can be audited against for standardised and improved care.
AB - Whilst professional bodies such as the Royal College and the American College of Obstetricians and Gynecologists have well-established standards for audit of management for most gynaecology disorders, such standards for premenstrual disorders (PMDs) have yet to be developed. The International Society of Premenstrual Disorders (ISPMD) has already published three consensus papers on PMDs covering areas that include definition, classification/quantification, clinical trial design and management (American College Obstetricians and Gynecologists 2011; Brown et al. in Cochrane Database Syst Rev 2:CD001396, 2009; Dickerson et al. in Am Fam Physician 67(8):1743–1752, 2003). In this fourth consensus of ISPMD, we aim to create a set of auditable standards for the clinical management of PMDs. All members of the original ISPMD consensus group were invited to submit one or more auditable standards to be eligible in the inclusion of the consensus. Ninety-five percent of members (18/19) responded with at least one auditable standard. A total of 66 auditable standards were received, which were returned to all group members who then ranked the standards in order of priority, before the results were collated. Proposed standards related to the diagnosis of PMDs identified the importance of obtaining an accurate history, that a symptom diary should be kept for 2 months prior to diagnosis and that symptom reporting demonstrates symptoms in the premenstrual phase of the menstrual cycle and relieved by menstruation. Regarding treatment, the most important standards were the use of selective serotonin reuptake inhibitors (SSRIs) as a first line treatment, an evidence-based approach to treatment and that SSRI side effects are properly explained to patients. A set of comprehensive standards to be used in the diagnosis and treatment of PMD has been established, for which PMD management can be audited against for standardised and improved care.
KW - PMD (premenstrual disorder)
KW - PMDD (premenstrual disorder/premenstrual dysphoric disorder)
KW - PMS (premenstrual syndrome)
UR - https://www.scopus.com/pages/publications/84976902064
U2 - 10.1007/s00737-016-0631-7
DO - 10.1007/s00737-016-0631-7
M3 - Article
C2 - 27378473
AN - SCOPUS:84976902064
SN - 1434-1816
VL - 19
SP - 953
EP - 958
JO - Archives of Women's Mental Health
JF - Archives of Women's Mental Health
IS - 6
ER -